Study guide
Vitrectomy and intraocular tamponades
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
Vitrectomy and intraocular tamponades
Key Takeaways Explain This Topic AI
Vitrectomy entry and instrumentation must be adapted to lens status and anatomy.
Gas, silicone oil and heavy liquids have different roles and complication profiles.
No flight or nitrous oxide is safe while an intraocular gas bubble remains; confirm disappearance rather than relying only on elapsed days.
Last updated: October 2026
Evolution and Mechanics of Pars Plana Vitrectomy (PPV)
Pars plana vitrectomy was conceptualized and pioneered by Robert Machemer in 1970 using a 17-gauge full-function instrument. Ophthalmic vitreoretinal surgery has since evolved from conventional 20-gauge vitrectomy (which required conjunctival peritomies, large scleral incisions, and sutured wound closure) to Micro-Incision Vitrectomy Surgery (MIVS) :
MIVS Calibres: 23-gauge ( 0.64 mm 0.64\,\text{mm} 0.64 mm ) , 25-gauge ( 0.50 mm 0.50\,\text{mm} 0.50 mm ) , and ultra-high-speed 27-gauge ( 0.40 mm 0.40\,\text{mm} 0.40 mm ) systems.
Transconjunctival Sutureless Cannulas: Trocar-cannula entry systems are inserted through the conjunctiva and sclera via angled, beveled incisions that create self-sealing, valved tunnels. This avoids conjunctival dissection, minimizes postoperative corneal astigmatism, accelerates wound healing, and reduces postoperative ocular inflammation and patient discomfort.
Anatomical Entry Sites: Sclerotomy Placement Landmarks
The pars plana of the ciliary body is an anatomically privileged, avascular zone measuring approximately 4 mm 4\,\text{mm} 4 mm in width (extending from the posterior edge of the ciliary processes at the pars plicata, situated 2 mm 2\,\text{mm} 2 mm posterior to the limbus, to the ora serrata, situated 6 − 7 mm 6-7\,\text{mm} 6 − 7 mm posterior to the limbus temporally and 5.5 − 6 mm 5.5-6\,\text{mm} 5.5 − 6 mm nasally):
Adult phakic eyes : Entry is commonly about 4 mm behind the limbus, adjusted for anatomy and technique; avoid lens and retinal injury.
In Pseudophakic or Aphakic Eyes: Sclerotomies are placed 3.5 mm 3.5\,\text{mm} 3.5 mm posterior to the corneal limbus . Because the native crystalline lens is absent, entering at 3.5 mm 3.5\,\text{mm} 3.5 mm maximizes surgical maneuverability while avoiding the anterior vitreous base and ora serrata.
Children : Entry planning depends on age and measured anatomy, with examination/ultrasound as needed. Adult distances and a generic paediatric distance cannot be applied to every eye.
Modern Vitrectomy Fluidics and Instrumentation
High-Speed Cutters: Contemporary vitrectomy probes feature dual-pneumatic drive mechanisms achieving cut rates of 5 , 000 5,000 5 , 000 to 10 , 000 10,000 10 , 000 cuts per minute (cpm) (up to 20 , 000 cpm 20,000\,\text{cpm} 20 , 000 cpm with dual-blade technology). Higher cut rates yield smaller vitreous bites, minimize tractional drag on the peripheral retina, and suppress intraocular pressure turbulence.
Wide-Angle Non-Contact Viewing Systems: Non-contact systems (e.g., BIOM, Resight) utilize wide-angle inverter optics to provide up to 130 ∘ 130^{\circ} 13 0 ∘ panoramic visualization of the peripheral retina, independent of corneal magnification or pupil constriction.
Chandelier Endoillumination: Dedicated transscleral fiber-optic light pipes anchored through independent trocars liberate both hands of the surgeon, enabling bimanual techniques for complex membrane peeling and proliferative vitreoretinopathy (PVR) dissection.
Intraocular Endotamponades: Gases vs. Silicone Oil
Intraocular tamponades provide surface tension and buoyancy across retinal breaks, sealing them against fluid ingress while chorioretinal retinopexy adhesion matures (which requires 10 to 14 days).
1. Intraocular Expansile Gases
Intraocular gases are inert, water-insoluble fluorochemicals. When injected as pure (100%) gas into the eye, nitrogen and oxygen from surrounding tissues rapidly diffuse down their partial pressure gradients into the bubble faster than the high-molecular-weight fluorochemical can diffuse out, causing predictable volumetric expansion:
Gas Tamponade Pure Gas Expansion Factor Time to Peak Expansion Intraocular Half-Life / Total Duration Non-Expansile (Isovolumetric) Mixture
Sulfur Hexafluoride ( S F 6 SF_6 S F 6 ) 2.0 × 2.0\times 2.0 × (doubles in volume) 24 24 24 to 48 hours 48\,\text{hours} 48 hours Lasts roughly 2–3 weeks , varying by eye and fill 20 % S F 6 20\%\ SF_6 20% S F 6 ( 20 % S F 6 + 80 % ambient air 20\%\ SF_6 + 80\%\ \text{ambient air} 20% S F 6 + 80% ambient air )
Perfluoroethane ( C 2 F 6 C_2F_6 C 2 F 6 ) 3.3 × 3.3\times 3.3 × (triples in volume) 48 48 48 to 72 hours 72\,\text{hours} 72 hours Lasts 4 4 4 to 5 weeks 5\,\text{weeks} 5 weeks 16 % C 2 F 6 16\%\ C_2F_6 16% C 2 F 6 ( 16 % C 2 F 6 + 84 % ambient air 16\%\ C_2F_6 + 84\%\ \text{ambient air} 16% C 2 F 6 + 84% ambient air )
Perfluoropropane ( C 3 F 8 C_3F_8 C 3 F 8 ) 4.0 × 4.0\times 4.0 × (quadruples in volume) 72 72 72 to 96 hours 96\,\text{hours} 96 hours Lasts 6 6 6 to 8 weeks 8\,\text{weeks} 8 weeks 12 % C 3 F 8 12\%\ C_3F_8 12% C 3 F 8 ( 12 % C 3 F 8 + 88 % ambient air 12\%\ C_3F_8 + 88\%\ \text{ambient air} 12% C 3 F 8 + 88% ambient air )
Caution
Absolute Contraindication to Air Travel and General Anesthesia with Nitrous Oxide:
Aviation / High Altitudes (Boyle's Law): According to Boyle's law ( P 1 V 1 = P 2 V 2 P_1V_1 = P_2V_2 P 1 V 1 = P 2 V 2 ), as ambient pressure plummets at commercial aircraft cabin altitudes ( 8 , 000 feet ≈ 565 mmHg 8,000\,\text{feet} \approx 565\,\text{mmHg} 8 , 000 feet ≈ 565 mmHg ), an intraocular gas bubble expands rapidly and uncontrollably. This causes catastrophic, blinding intraocular pressure elevation ( > 60 − 80 mmHg >60-80\,\text{mmHg} > 60 − 80 mmHg ), central retinal artery occlusion, and ischemic optic neuropathy. Patients MUST NOT fly, drive across mountain passes, or undergo hyperbaric therapy until the gas bubble is completely resorbed.
Nitrous Oxide ( N 2 O N_2O N 2 O ) Anesthesia: Nitrous oxide is 34 times more soluble in blood than nitrogen. It rapidly diffuses from the bloodstream into the intraocular gas bubble, causing explosive bubble expansion within minutes. N 2 O N_2O N 2 O is strictly contraindicated in patients with an intraocular gas bubble.
2. Silicone oil is non-resorbable and provides prolonged tamponade in selected complex detachments. Indication, later removal, posture and pressure/retinal surveillance depend on the individual eye. It does not provide universally immediate functional vision or require permanent retention.
1,000 cSt vs. 5,000 cSt Viscosity:
1,000 Centistokes (cSt): Lower viscosity; significantly easier and faster to inject and aspirate through small-calibre MIVS cannulas. However, it undergoes earlier emulsification.
5,000 Centistokes (cSt): Higher viscosity; exhibits superior resistance to shear stress and significantly delays emulsification , making it preferable for long-term tamponade ( > 6 >6 > 6 months).
Complications of Silicone Oil:
Emulsification: Over time, mechanical shear stresses break the oil bubble into micro-droplets ("tiny bubbles" in the anterior chamber / "inverse hypopyon" floating superiorly), clogging the trabecular meshwork and inciting intractable secondary open-angle glaucoma.
Pupillary Block Glaucoma in Aphakic Eyes: Silicone oil has a specific gravity of 0.97 g/cm 3 0.97\,\text{g/cm}^3 0.97 g/cm 3 (lighter than water) and floats superiorly. In aphakic eyes, it can herniate anteriorly to block the pupil. To prevent pupillary block, a surgical inferior peripheral iridectomy (Ando iridectomy at 6 o'clock) is mandatory, allowing aqueous humor to circulate from the inferior posterior chamber into the anterior chamber.
Refraction : Silicone oil changes the posterior lens-interface power, commonly producing a hyperopic shift in phakic/pseudophakic eyes. Magnitude depends on lens shape and IOL design; aphakic oil-filled eyes can shift myopically. It does not reverse the crystalline lens into a divergent lens.
Other Complications: Band keratopathy, corneal endothelial decompensation, and accelerated nuclear sclerotic cataract formation in many phakic eyes within 12 − 24 12-24 12 − 24 months.
Heavy Silicone Oil (e.g., Densiron, Oxane HD): Formulated by blending silicone oil with high-density fluorinated alkanes (specific gravity > 1.0 g/cm 3 >1.0\,\text{g/cm}^3 > 1.0 g/cm 3 ). Because it sinks to the bottom of the vitreous cavity, heavy oil provides targeted inferior tamponade for complex inferior PVR without requiring prolonged prone posturing.